Krystal Biotech (KRYS) Asset Utilization Ratio (2023 - 2026)

Krystal Biotech has disclosed Asset Utilization Ratio across 4 years of filings, most recently posting 0.31 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.31, down 2.38% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.31 (down 2.38% YoY), and the FY2025 annual result was 0.33, up 5.05% from the prior year.
• Asset Utilization Ratio came in at 0.31 for Q1 2026 at Krystal Biotech, up from 0.3 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.32 in Q2 2025 to a low of 0.01 in Q3 2023.
• The 4-year median for Asset Utilization Ratio is 0.29 (2024), against an average of 0.23.
• Across the five-year window, Asset Utilization Ratio soared 2091.08% in 2024 and retreated 2.38% in 2026, its largest moves.
• Krystal Biotech's Asset Utilization Ratio stood at 0.06 in 2023, then surged by 352.34% to 0.29 in 2024, then rose by 6.04% to 0.3 in 2025, then gained by 1.08% to 0.31 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.31 (Q1 2026), 0.3 (Q4 2025), and 0.31 (Q3 2025), per Business Quant data.